- Home
- BNR vs AAME Comparison
BNR vs AAME Comparison
Compare BNR & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- AAME
- Stock Information
- Founded
- BNR 2014
- AAME 1968
- Country
- BNR China
- AAME United States
- Employees
- BNR N/A
- AAME N/A
- Industry
- BNR Medical Specialities
- AAME Life Insurance
- Sector
- BNR Health Care
- AAME Finance
- Exchange
- BNR Nasdaq
- AAME Nasdaq
- Market Cap
- BNR 30.9M
- AAME 28.3M
- IPO Year
- BNR 2020
- AAME N/A
- Fundamental
- Price
- BNR $2.84
- AAME $1.52
- Analyst Decision
- BNR
- AAME
- Analyst Count
- BNR 0
- AAME 0
- Target Price
- BNR N/A
- AAME N/A
- AVG Volume (30 Days)
- BNR 17.2K
- AAME 18.4K
- Earning Date
- BNR 05-28-2025
- AAME 05-13-2025
- Dividend Yield
- BNR N/A
- AAME 1.33%
- EPS Growth
- BNR N/A
- AAME N/A
- EPS
- BNR N/A
- AAME N/A
- Revenue
- BNR $70,669,261.00
- AAME $188,227,000.00
- Revenue This Year
- BNR $136.32
- AAME N/A
- Revenue Next Year
- BNR N/A
- AAME N/A
- P/E Ratio
- BNR N/A
- AAME N/A
- Revenue Growth
- BNR N/A
- AAME 0.77
- 52 Week Low
- BNR $2.62
- AAME $1.25
- 52 Week High
- BNR $8.99
- AAME $2.03
- Technical
- Relative Strength Index (RSI)
- BNR 23.18
- AAME 52.78
- Support Level
- BNR $2.77
- AAME $1.38
- Resistance Level
- BNR $3.48
- AAME $1.52
- Average True Range (ATR)
- BNR 0.35
- AAME 0.12
- MACD
- BNR 0.04
- AAME 0.02
- Stochastic Oscillator
- BNR 5.93
- AAME 81.22
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.